Clinicians should be aware of proton pump inhibitor-related changes in the gastric mucosa

DOI QR Code

Gwang Ha Kim (Department of Internal Medicine, Pusan National University School of Medicine and Biomedical Research Institute, Pusan National University Hospital)

Nocon M, Labenz J, Jaspersen D, et al. Long-term treatment of patients with gastro-oesophageal reflux disease in routine care: results from the ProGERD study. Aliment Pharmacol Ther 2007;25:715-722.
Joel A, Konjengbam A, Viswanath Y, et al. Endoscopic radiofrequency Stretta therapy reduces proton pump inhibitor dependency and the need for anti-reflux surgery for refractory gastroesophageal reflux disease. Clin Endosc 2024;57:58-64.
Welsch L, May A, Blasberg T, et al. Bile acid sequestrants in poor healing after endoscopic therapy of Barrett's esophagus. Clin Endosc 2023;56:194-202.
Kim GH. Proton pump inhibitor-related gastric mucosal changes. Gut Liver 2021;15:646-652.
Haruma K, Kato M, Inoue K, et al. Kyoto classification of gastritis. 2nd ed. Tokyo: Nihon Medical Center; 2019.
Hatano Y, Haruma K, Kamada T, et al. Factors associated with gastric black spot, white flat elevated mucosa, and cobblestone-like mucosa: a cross-sectional study. Digestion 2018;98:185-193.
Majima K, Muraki Y, Shimamoto T. Multiple white and flat elevated lesions observed in the stomach: a prospective study of clinical characteristics and risk factors. Intern Med 2018;57:2613-2619.
Hasegawa R, Yao K, Kanemitsu T, et al. Association between occurrence of multiple white and flat elevated gastric lesions and oral proton pump inhibitor intake. Clin Endosc 2024;57:65-72.
Uedo N, Yamaoka R, Yao K. Multiple white flat lesions in the gastric corpus are not intestinal metaplasia. Endoscopy 2017;49:615-616.